M. Peetermans
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Blood groups and transfusion
- Platelet Disorders and Treatments
- Biochemistry top 1%
- Blood transfusion and management
Papers in
- Hematology 42
- Acute Myeloid Leukemia Research 15
- Blood groups and transfusion 12
- Hematopoietic Stem Cell Transplantation 8
- Multiple Myeloma Research and Treatments 6
- Genetics 19
- Chronic Lymphocytic Leukemia Research 14
M. Peetermans
69 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 111
- Hematology 1.4k
- Biochemistry 475
- Genetics 310
- Management of Technology and Innovation 190
- Critical Care and Intensive Care Medicine 93
Countries citing papers authored by M. Peetermans
This map shows the geographic impact of M. Peetermans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Peetermans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Peetermans more than expected).
Fields of papers citing papers by M. Peetermans
This network shows the impact of papers produced by M. Peetermans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Peetermans. The network helps show where M. Peetermans may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Peetermans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 31 | |
| 2 | 1997 | 94 | |
| 3 | 1996 | 76 | |
| 4 | 1996 | 96 | |
| 5 | Comparison of quality of life (QOL) of patients with acute myelogenous leukemias (AML) in long-term first complete remission (CR) after bone marrow transplantation (BMT) - Allogeneic or autologous - Or intensive chemotherapy consolidation (ICC): EORTC-GIMEMA AML 8A study | 1995 | 1 |
| 6 | 1994 | 59 | |
| 7 | 1994 | 138 | |
| 8 | 1993 | 307 | |
| 9 | 1992 | 6 | |
| 10 | 1992 | 91 | |
| 11 | 1991 | 3 | |
| 12 | 1991 | 23 | |
| 13 | 1991 | 34 | |
| 14 | 1990 | 4 | |
| 15 | 1990 | 4 | |
| 16 | 1989 | 18 | |
| 17 | 1989 | 302 | |
| 18 | 1988 | 1 | |
| 19 | 1987 | 7 | |
| 20 | 1983 | 22 |
About M. Peetermans
M. Peetermans is a scholar working on Hematology, Genetics, Biochemistry, Immunology and Management of Technology and Innovation, having authored 72 papers that have together received 2.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), Chronic Lymphocytic Leukemia Research (14 papers), Blood groups and transfusion (12 papers), Acute Lymphoblastic Leukemia research (10 papers), Hematopoietic Stem Cell Transplantation (8 papers), Blood transfusion and management (7 papers), Lymphoma Diagnosis and Treatment (7 papers) and Multiple Myeloma Research and Treatments (6 papers). The work is most often cited by research in Hematology (1.4k citations), Biochemistry (475 citations), Genetics (310 citations), Management of Technology and Innovation (190 citations) and Critical Care and Intensive Care Medicine (93 citations). M. Peetermans has collaborated with scholars based in Belgium, France and Netherlands. Frequent co-authors include L. Muylle, E. Wouters, R. De Bock, Stefan Suciu, R Zittoun, G. Solbu, Dirk R. Van Bockstaele, Bob Löwenberg, U. Jehn and J. Abels. Their work appears in journals such as Vox Sanguinis, Annals of Hematology, Transfusion, Cytometry and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.